Search

everythinglearnresearchcommunity

for

Search:↓

More people are using online platforms for hair loss treatment due to convenience and privacy.

Oral tofacitinib can significantly improve recalcitrant lichen planopilaris.

These medications for BPH have known risks and may have new side effects.

A 50 mg daily dose of ritlecitinib is effective for alopecia areata, with temporary treatment breaks up to 6 weeks not affecting results.

Ritlecitinib shows promise as a versatile treatment for various autoimmune and inflammatory diseases.

Combination therapy is better for long-term control and outcomes in type 2 diabetes.

Tofacitinib shows promise for treating severe alopecia areata with good safety and effectiveness.

Injecting 2 ml of TEEV every 4 weeks is better because it has the same benefits but fewer side effects.

Patients with alopecia areata prefer treatments that regrow scalp hair quickly over how often they need to take the medication.

Using finasteride with TIP extends time off period for prostate cancer patients.

Tofacitinib caused significant hair regrowth in adolescents with alopecia universalis who didn't respond to other treatments.

Tofacitinib may help treat both alopecia areata and inflammatory bowel disease.

Tofacitinib is a promising and safe treatment for moderate to severe alopecia areata.

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.

Reporter characteristics affect detection of hair loss from cancer therapy.

TURP is the best treatment for BPH, but some patients prefer medications like alpha-blockers and finasteride.

Oral tofacitinib effectively regrows hair in children with alopecia areata without major side effects.

Tailored treatment is crucial for elderly men with BPH due to potential risks and benefits of medications.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

Combining pemetrexed with platinum drugs improves treatment outcomes and quality of life for elderly patients with advanced lung adenocarcinoma.

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.

Nitroxide drugs can safely and effectively treat age-related diseases like macular degeneration and cardiovascular issues.

DrugNet effectively identifies new uses for existing drugs and may save resources in drug development.

COVID-19 infection rates were low in patients with immune diseases, regardless of their treatment type.

Tofacitinib may help treat Lichen Planopilaris, but more research is needed.

Proxalutamide significantly lowered hospitalization rates in women with mild-to-moderate COVID-19.

Tofacitinib effectively treated severe hair loss in a patient who didn't respond to other treatments.

Tofacitinib helped an 8-year-old child recover from a type of hair loss that is hard to treat.

Adults with classic congenital adrenal hyperplasia value medication that prevents weight gain from glucocorticoids the most.